blinatumomab
astellas pharmaceuticals,amgen
['leusm', 'blinatumomab']
congress #eha2022 | francesco muriano reported results of blinatumomab+dli in 3 mrd-positive patients after allogeneic hsct. 2 pts reached stable mrd undetectable status and 2 subsequently developed cns relapse, none received cns prophylaxis post-hsct #allsm #leusm 
A global education platform providing clinical updates on acute lymphoblastic leukemia. #leusm #allsm